Pernilla Stridh

Our IMSGC and MultipleMS study on genetic determinants of multiple sclerosis (MS) severity is published in Nature! Lead author @AdilHarroud has nicely summarized the main findings in the tweet below. A big thank you to all patients who participated!

@AdilHarroud @jacoblmccauley @aletta_vdbosch @MarijneVd @TillPopill @SteffanBos @Calabre04804429 @ccots @KateFitzg @jagodic_maja @GrantPParnell @XMontalban @npatsop @pvilloslada1 @ZippFrauke @IngridKockum @AdilHarroud thank you for doing the heavy lifting!

Recognizing *some* of our amazing co-authors on Twitter @PStridhKI @jacoblmccauley @aletta_vdbosch @MarijneVd @TillPopill @SteffanBos @Calabre04804429 @ccots @KateFitzg @jagodic_maja @GrantPParnell @XMontalban @npatsop @pvilloslada1 @ZippFrauke @IngridKockum and many more!

🎉 Our IMSGC and MultipleMS work on genetic determinants of multiple sclerosis (MS) severity is out in Nature! Read for the main findings of the study, led by myself and co-advised by Sergio Baranzini and Stephen Sawcer. #MS #Genetics 🧬 doi.org/10.1038/s41586…

A summary of our gene discovery boils it down to essentials.

Researchers identify the first genetic variant associated with disease severity in #MultipleSclerosis, opening the door to preventing long-term disability. New study in @Nature by Ingrid Kockum, @PStridhKI and colleagues @UCSF @Cambridge_Uni. #MS #Genetics news.ki.se/new-gene-disco…

New gene discovery that gives hope of fighting severe MS was published in Nature yesterday (ki.se)

Am full of inspiration after the Nordic Society of Human Genetics and Precision Medicine Workshop in Estonia.